Clinical Trial Update: Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive Ascites [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating intraperitoneal SK-NK cell injections for advanced ovarian cancer with massive ascites; recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• SK-NK cell (allogeneic natural killer cells)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Ovarian Neoplasms Malignant, Ascites | Phase 1, Phase 2 | Status: RECRUITING